Molecular Mechanisms of Genomic Reprogramming during Germ Cell Specification

生殖细胞规范过程中基因组重编程的分子机制

基本信息

  • 批准号:
    8097319
  • 负责人:
  • 金额:
    $ 5.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Germ cells are remarkable in that, of all the cell types found in an organism they alone retain the ability to give rise to all the embryonic and extra-embryonic cell types that contribute to an organism. This property of totipotency is protected in primordial germ cells (PGCs) by their maintenance of a transcriptionally repressed genome. Two temporally and biochemically distinct mechanisms accomplish this objective in C. elegans. Initially, a C.elegans-specific maternal protein PIE-1, specifically partitioned to the germ line blastomeres, inhibits activation of RNA polymerase. Shortly, after the birth of the PGCs, PIE-1 is degraded and dramatic genome-wide chromatin remodeling occurs to sustain transcriptional repression. However, pathways involved in regulating effectors of global remodeling of the genome remain unknown. A significant goal of this proposal is to uncover molecular mechanisms underlying the specific loss of various marks of 'active' chromatin in newly bom germ cells. The role of RNA polymerase, histone variants and post-translational modifications will be interrogated in the control of these erasure events. Initial experiments also suggest specific activation of histone deacetylase (HDAC) activity at the birth of the primordial germ cells, Z2 and Z3. In complementary approaches, using loss-of-function mutants, RNA interference and transgenic misexpression, the consequence of persistent histone acetylation on the germ-line will be elucidated. Finally, translational and post-translational control of HDAC activity will be probed using genetic and biochemical approaches. Public Health Relevance: These studies address a fundamental question of biomedical relevance: how do embryonic cells, and for that matter, stem cells retain the ability to differentiate into all lineages of the adult animal? The answer to this question will undoubtedly have enormous ramifications for manipulating cells to generate tissue-specific progenitors that could ultimately be used to cure debilitating, degenerative illnesses such as Parkinson's. Additionally, since histone deacetylation has been implicated in aberrant gene silencing in cancerous cells and HDAC inhibitors are being developed as effective anti-cancer drugs, our long-term goal is to utilize our knowledge of histone deacetylation regulation to increase the specificity of next generation epigenetic therapies.
描述(由申请人提供):生殖细胞的显着之处在于,在生物体中发现的所有细胞类型中,它们单独保留了产生对生物体有贡献的所有胚胎和胚胎外细胞类型的能力。原始生殖细胞(PGC)通过维持转录抑制基因组来保护这种全能性。在秀丽隐杆线虫中,两种时间上和生化上不同的机制实现了这一目标。最初,线虫特异性母体蛋白 PIE-1,专门分配到种系卵裂球,抑制 RNA 聚合酶的激活。 PGC 诞生后不久,PIE-1 被降解,并且发生剧烈的全基因组染色质重塑以维持转录抑制。然而,参与调节基因组整体重塑效应子的途径仍然未知。该提案的一个重要目标是揭示新生生殖细胞中“活性”染色质各种标记的特定丢失的分子机制。 RNA 聚合酶、组蛋白变体和翻译后修饰的作用将在这些擦除事件的控制中受到质疑。初步实验还表明,组蛋白脱乙酰酶 (HDAC) 活性在原始生殖细胞 Z2 和 Z3 诞生时被特异性激活。在补充方法中,使用功能缺失突变体、RNA 干扰和转基因错误表达,将阐明种系上持续组蛋白乙酰化的后果。最后,将使用遗传和生化方法探讨 HDAC 活性的翻译和翻译后控制。 公共健康相关性:这些研究解决了生物医学相关性的一个基本问题:胚胎细胞以及干细胞如何保留分化成成年动物所有谱系的能力?这个问题的答案无疑将对操纵细胞产生组织特异性祖细胞产生巨大影响,这些祖细胞最终可用于治疗帕金森氏症等衰弱的退行性疾病。此外,由于组蛋白脱乙酰化与癌细胞中的异常基因沉默有关,并且 HDAC 抑制剂正在开发为有效的抗癌药物,因此我们的长期目标是利用我们对组蛋白脱乙酰化调节的知识来提高下一代表观遗传疗法的特异性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sujata Bhattacharyya其他文献

Sujata Bhattacharyya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sujata Bhattacharyya', 18)}}的其他基金

Molecular Mechanisms of Genomic Reprogramming during Germ Cell Specification
生殖细胞规范过程中基因组重编程的分子机制
  • 批准号:
    7920163
  • 财政年份:
    2009
  • 资助金额:
    $ 5.87万
  • 项目类别:
Molecular Mechanisms of Genomic Reprogramming during Germ Cell Specification
生殖细胞规范过程中基因组重编程的分子机制
  • 批准号:
    7752883
  • 财政年份:
    2009
  • 资助金额:
    $ 5.87万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了